Acta Scientific Pharmacology

Research Article Volume 2 Issue 10

A Multinational, Across the Countries of COVID-19 Vaccination Drive Among Healthcare Professionals Through Human Health Research Web Based Portal Survey Study Among Participant’s Data Analysis of Post-inoculation Symptoms After First and Second Dose of COVID-19 Vaccine

Pallavi Kaulwar*

Ajeenkya DY Patil University, Pune, India

*Corresponding Author: Pallavi Kaulwar, Ajeenkya DY Patil University, Pune, India.

Received: June 01, 2021; Published: September 23, 2021

Abstract

  COVID-19 vaccinations have recently been made available in a number of countries. Despite the fact that the vaccine's protective effectiveness is regularly emphasized, little is known about the post-vaccination experience in the real world outside of clinical trial conditions.

Knowledge of what to expect following vaccination will aid in public education, dispelling misconceptions, and reducing vaccine apprehension.

Keywords: Human Health Research; Adverse Event; Online Survey; Post Inoculation of Symptoms; Data Analysis

References

  1. Lianpan Dai and George F Gao. “Viral targets for vaccines against COVID-19”. Nature Review of Immunology2 (2021): 73-82.
  2. Marcelle Moura Silveira., et al. “DNA vaccines against COVID-19: Perspectives and challenges”. Life Science 267 (2021): 118919.
  3. Camille Locht. “Vaccines against COVID-19”. Anaesthesia, Critical Care and Pain Medicine 6 (2020): 703-705.
  4. Roy L Soiza., et al. “Efficacy and safety of COVID- 19 vaccines in older people”. Age Ageing2 (2021): 279-283.
  5. Kumaragurubaran Karthik., et al. “Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19”. Human Vaccine Immunotherapy12 (2020): 3055-3060.
  6. T Wibawa. “COVID-19 vaccine research and development: ethical issues”. Tropical Medicine and International Health 1 (2021): 14-19.
  7. Shan Su., et al. “Learning from the past: development of safe and effective COVID-19 vaccines”. Nature Review of Microbiology3 (2021): 211-219.
  8. Qian Li and Hongzhou Lu. “Latest updates on COVID-19 vaccines”. Bioscience Trends6 (2021): 463-466.
  9. Ji-Wang Chen., et al. “Potential of live pathogen vaccines for defeating the COVID-19 pandemic: History and mechanism”. Journal of Medical Virology9 (2020): 1469-1474.
  10. “Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer- BioNTech COVID-19 Vaccine - United States, December 14-23, 2020”. MMWR Morbidity and Mortality Weekly Report2 (2020): 46-51.
  11. Kevin Ita. “Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development”. Archives of Medical Research1 (2021): 15-24.
  12. Janet Sultana., et al. “Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations”. Expert Rev Vaccines 10 (2020): 919-936.
  13. Harald Brüssow. “Efforts towards a COVID-19 vaccine”. Environmental Microbiology10 (2020): 4071-4084.
  14. Kanta Subbarao. “COVID-19 vaccines: time to talk about the uncertainties”. Nature7830 (2020): 475.
  15. Saman Soleimanpour and Atieh Yaghoubi. “COVID-19 vaccine: where are we now and where should we go?”. Expert Review of Vaccines 1 (2020): 23-44.
  16. Tom Shimabukuro and Narayan Nair. “Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine”. JAMA 8 (2020): 780-781.
  17. Kenneth Lundstrom. “Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID- 19”. Viruses 11 (2020): 1324.
  18. Inayat Ur Rahman., et al. “COVID-19 - Important considerations for developing and using a vaccine”. Human Vaccine Immunotherapy2 (2021): 414-415.
  19. Nidhi Singh., et al. “Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19”. Journal of Chemical Neuroanatomy 110 (2020): 101874.
  20. Saad Shakir., et al. “How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine”. Drug Safety1 (2021): 1-5.
  21. Heidi Ledford. “Could mixing COVID vaccines boost immune response?”. Nature7846 (2021): 375-376.
  22. Ewen Callaway. “Why Oxford's positive COVID vaccine results are puzzling scientists”. Nature7836 (2020): 16-18.

Citation

Citation: Pallavi Kaulwar. “A Multinational, Across the Countries of COVID-19 Vaccination Drive Among Healthcare Professionals Through Human Health Research Web Based Portal Survey Study Among Participant’s Data Analysis of Post-inoculation Symptoms After First and Second Dose of COVID-19 Vaccine". Acta Scientific Pharmacology 2.10 (2020): 02-17.

Copyright

Copyright: © 2021 Pallavi Kaulwar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US